FDA’s cover photo
FDA

FDA

Government Administration

Silver Spring, MD 879,152 followers

About us

The Food and Drug Administration is an agency within the Department of Health and Human Services. The FDA is responsible for protecting the public health by ensuring the safety, efficacy, and security of human and veterinary drugs, biological products, and medical devices; and by ensuring the safety of our nation's food supply, cosmetics, and products that emit radiation. FDA also has responsibility for regulating the manufacturing, marketing, and distribution of tobacco products to protect the public health and to reduce tobacco use by minors. FDA is responsible for advancing the public health by helping to speed innovations that make medical products more effective, safer, and more affordable and by helping the public get the accurate, science-based information they need to use medical products and foods to maintain and improve their health. FDA also plays a significant role in the Nation's counterterrorism capability. FDA fulfills this responsibility by ensuring the security of the food supply and by fostering development of medical products to respond to deliberate and naturally emerging public health threats.

Website
http://www.fda.gov/
Industry
Government Administration
Company size
10,001+ employees
Headquarters
Silver Spring, MD
Type
Government Agency
Specialties
Food, Drugs, Medical Devices, Vaccines Blood and Biologics, Animal and Veterinary, Cosmetics, Radiation-Emitting Products, Tobacco Products, Regulatory Research, and Toxicological Regulatory Research

Locations

Employees at FDA

Updates

  • View organization page for FDA

    879,152 followers

    Today, the FDA is taking action to restrict the sale of unapproved ingestible fluoride prescription products for young children. We’ve sent notices to 4 companies outlining the agency’s intention to take action against those that market unapproved fluoride-containing ingestible drug products. https://lnkd.in/eUaszBw6 FDA concluded that such products should not be used in children under age three or by older children who are not at high risk of tooth decay. For the same reason fluoride may work to kill bacteria on teeth, it may also alter the gut microbiome, which may have broader health implications. Better alternatives exist to protect children's teeth.

    • No alternative text description for this image
  • View organization page for FDA

    879,152 followers

    The FDA posted materials for the virtual Digital Health Advisory Committee meeting scheduled Nov. 6. The committee will discuss and make recommendations on the topic of generative AI-enabled digital mental health medical devices. Access the meeting agenda, roster, executive summary, discussion questions, and webcast link on our website. Also, learn how to submit written public comments. https://lnkd.in/ewCGN3a5

    • No alternative text description for this image
  • View organization page for FDA

    879,152 followers

    Today, the FDA issued the first-ever Emergency Use Authorization for an animal drug. FDA concluded that, based on the scientific evidence available, it is reasonable to believe that the drug may be effective in treating New World screwworm infestations in dogs and puppies, and the known and potential benefits of the product outweigh its known and potential risks. https://lnkd.in/es4hTudS

    • No alternative text description for this image
  • View organization page for FDA

    879,152 followers

    Today, FDA approved revumenib for adult and pediatric patients 1 year and older with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleophosmin 1 (NPM1) mutation who have no satisfactory alternative treatment options.  https://lnkd.in/epxA9sGU   The prescribing information includes warnings and precautions for differentiation syndrome, QTc interval prolongation, and embryo-fetal toxicity.    Learn more in the FDA-approved prescribing information at: https://lnkd.in/emUfeBq 

    • No alternative text description for this image
  • View organization page for FDA

    879,152 followers

    Registration is now open to attend the FDA Rare Disease Innovation Hub’s November 20th Rare Disease Innovation, Science, and Exploration (RISE) Workshop on individualized therapies.   This public workshop will examine the emerging science and regulatory environment for individualized medicine programs. It will provide opportunities for members of the rare disease community, including researchers, sponsors, patients, patient advocates, and regulators, to share their experiences with individualized medicine approaches.   Register here: https://lnkd.in/euFBKM9U

    • No alternative text description for this image
  • View organization page for FDA

    879,152 followers

    FDA released the guidance snapshot for the final guidance Conducting Clinical Trials with Decentralized Elements. https://lnkd.in/e--DE9Uv https://lnkd.in/exDQdykh FDA’s Guidance Snapshot Pilot Program aims to increase the general public’s awareness of and engagement with FDA guidance documents—and support the efficient application of the recommendations. The snapshot highlights key points in the guidance document and is not a substitute for the guidance document. 

    • No alternative text description for this image
  • View organization page for FDA

    879,152 followers

    FDA issued guidance today permitting animal drug sponsors to use dual labeling for FDA-approved animal drugs if FDA conditionally approves the same drug for New World screwworm-related indications. This action helps streamline labeling changes on animal drug products needed to respond to the NWS threat at the U.S./Mexico border. https://lnkd.in/eBA58bPe

    • No alternative text description for this image

Affiliated pages

Similar pages

Browse jobs